Pfizer: Prevenar 13 To Be Available At Lowest Price For Humanitarian Emergencies

(RTTNews) - Drug major Pfizer Inc. (PFE) announced Friday that Prevenar 13 Vaccine will be available at lowest price for humanitarian emergencies.

In a major expansion of its humanitarian assistance program, the company enabled broader access to its vaccine, by offering its new multi-dose vial or MDV at what will be the lowest prevailing global price, currently $3.10 per dose.

Pfizer will also donate all sales proceeds for the first year of this program to humanitarian groups supporting the refugee crisis.

In the immediate term, Pfizer will meet humanitarian emergency needs through a short-term donation of the single-dose vial of Prevenar 13, which is available for expedited delivery.

Starting in 2017, refugees can receive the newest version of Prevenar 13, the MDV. This presentation is scheduled to be introduced early next year and contains four doses of Prevenar 13 in the same-sized vial that currently contains a single dose. This four-in-one vial is specially designed for helping health workers in humanitarian emergencies.